Elevance Health Q1 EPS $8.30 GAAP, $9.46 adjusted; raises full-year guidance

Elevance Health, Inc.

2023-Q1 EPS reported $8.30 revenue$42,172,000,000

GAAP net income $8.30/share; adjusted net income $9.46/share, beating expectations.
Operating revenue $41.9B, up 10.6% YoY; operating gain $2.8B, up 16.6% YoY.
Medical enrollment 48.1M, up 1.3M YoY driven by Medicaid, Medicare Advantage, ACA.
Raised 2023 outlook: GAAP EPS >$29.50, adjusted EPS >$32.70.
Q2 dividend $1.48/share declared; payable June 23 to holders of record June 9.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Elevance Health, Inc. reported the quarter ended March 31, 2023 results: revenue $41.9 billion, net income $8.30 per share, EPS $8.30 per share. Guidance raised.

Period: the quarter ended March 31, 2023
Revenue: $41.9 billion
Net income: $8.30 per share
EPS: $8.30 per share
Guidance: raised
Result: reported results

Exact text from the filing

was $8.30 per share, including net negative adjustment items of $1.16 per share. Adjusted net income was $9.46* per share. • Operating revenue grew 10.6% year-over-year to $41.9 billion • Operating gain grew 16.6% year-over-year to $2.8 billion • Medical enrollment increased 1.3 million members year-over-year to 48.1 million members • Second quarter 2023

View on SEC.gov

Browse all earnings releases →

Elevance Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-105591

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.